Search

Search Constraints

You searched for: Author/Creator Gros, A

Search Results

1. 349PDynamics of clinical biomarkers as predictors of immunotherapy (IT) benefit in metastatic melanoma (MM) patients (pts) treated in reference institution. (25th November 2018)

2. 18PDissecting the antitumor immune response upon PARP inhibition in homologous recombination repair (HRR)-deficient tumors. (17th December 2018)

3. 92PVall d'Hebron Institute of Oncology (VHIO) immuno-oncology prognostic index (VIO): A new tool for improved patient (pt) selection in phase I (Ph1) trials with immune checkpoint inhibitors (ICI). (23rd October 2018)

4. 22P Early changes in plasma cell-free DNA (cfDNA) as a predictive biomarker of immune checkpoint inhibitors (ICIs) efficacy. (15th December 2019)

5. O-267 Uterine volume is dramatically decreased in Stem Cell Hematopoietic Transplantation childhood survivors whatever the conditioning regimen. A case-control MRI study in the L.E.A cohort. (30th June 2022)

6. First xenograft and cell line of primary cutaneous diffuse large B-cell lymphoma, leg type. (September 2022)